Medical marijuana; transportation license; allowing transport of medical marijuana to patients; warehouses; inventory manifests and logs; signage; effective date.
HB2897 revises Oklahoma’s medical marijuana transportation laws and expands the circumstances under which medical marijuana may be delivered and stored. The bill updates the medical marijuana transporter license framework, including issuance to qualifying applicants and certain licensed businesses, and expressly allows transport from dispensaries to certain patients who have a Veterans Affairs Benefit Summary Letter showing a 100% disability rating. It also authorizes transporter licensees to contract with multiple businesses, operate licensed premises for temporary storage and centralized distribution, and maintain one or more warehouses if each location is separately permitted and approved by the Oklahoma Medical Marijuana Authority (OMMA).
The bill adds detailed operational and recordkeeping requirements for transporters and dispensaries. It requires GPS-equipped vehicles, locked and labeled containers, secure vehicle storage, seed-to-sale tracking, inventory manifests with specified origin/destination and quantity information, and seven-year retention of manifests and logs. For patient deliveries, it requires sales receipts before transport and mandates that all delivery sales to eligible patients occur through a third-party vendor using identity verification tools, including driver’s license upload, patient license verification, facial mapping, and final delivery confirmation. The bill also creates a two-year Medical Marijuana Veterans Transporter Pilot Program and requires dispensaries to post a pregnancy/THC warning sign in specified locations.
HB2897 would amend Sections 424 and 427.16 of Title 63 and create new codified sections for the pilot program and dispensary signage. In practical terms, it broadens OMMA’s licensing and enforcement responsibilities, adds warehouse permitting authority, and imposes new compliance obligations on transporters, dispensaries, and delivery vendors. It also establishes a new warning-sign requirement funded by dispensary owners and sets the act’s effective date for November 1, 2025.
The overall sentiment in the recorded votes appears generally supportive in committee and on initial floor consideration, with strong majorities in the House and Senate committees and on third reading. However, the final House fourth-reading vote was defeated, indicating that support weakened at the end of the process or that unresolved concerns remained. The bill’s focus on veteran access and tighter delivery controls likely helped early support, while the more complex delivery-verification rules, warehouse expansion, and new compliance burdens may have contributed to later resistance.
The main points of contention appear to be the scope of delivery and storage expansion, the use of third-party vendors and biometric-style verification for patient deliveries, and the added regulatory burden on dispensaries and transporters. Supporters likely viewed the bill as improving access for severely disabled veterans and clarifying transport rules, while opponents may have been concerned about privacy, implementation costs, administrative complexity, and whether the new warehouse and delivery provisions go beyond the state’s existing medical marijuana framework.
HB2897 would amend Oklahoma’s medical marijuana statutes governing transporter licenses, transport rules, warehouse storage, inventory manifests, and patient delivery. It expands who may receive transport services, authorizes temporary storage and warehouse operations under OMMA-issued permits, and imposes detailed tracking, security, and documentation requirements on licensed transporters, dispensaries, and receiving businesses. It also creates a temporary veterans-focused pilot program and adds a mandatory pregnancy/THC warning sign requirement for dispensaries.
The bill appears to have had mixed but initially favorable support. It passed committee stages and early floor votes with strong margins, suggesting broad interest in the transportation, delivery, and veterans-access provisions. The final House fourth-reading vote failed, however, indicating that support was not durable and that some members had reservations about the bill’s regulatory structure or policy scope.
The most notable contention centers on the bill’s expanded delivery and storage system. Critics may object to requiring third-party vendor platforms, facial verification, and other digital identity checks for patient deliveries, as well as the added costs and compliance obligations for dispensaries and transporters. The warehouse-permitting provisions and broader authority to store and distribute product at multiple locations may also raise concerns about oversight and market expansion. Supporters, by contrast, likely emphasized improved access for 100% disabled veterans and clearer, more secure transport rules.